Cahill Gordon & Reindel is launching a technology IP litigation practice after hiring a three-strong team of highly regarded trial lawyers from King & Spalding.
The trio, who will be based in the firm’s Washington DC office, comprises Chris Campbell, Britton Davis and Alfonso Garcia Chan.
Herb Washer, chair of Cahill’s executive committee, said the new recruits would extend the reach of its IP practice, “building on our life sciences foundation”, and would represent clients with IP interests in software, hardware and telecommunications technologies, as well as biomaterials and medical devices.
Campbell co-founded and led the innovation protection group at King & Spalding, where he spent more than six years. He will serve as chair of Cahill’s technology IP litigation practice.
As a first chair trial lawyer, Campbell has more than three decades of experience trying complex patent infringement, trade secret and technology cases.
His clients include disruptive start-ups as well as established brands with expertise in technologies ranging from artificial intelligence to medical and mechanical devices. He has represented plaintiffs and defendants in patent trials in the most active venues across the US.
He also previously served as a partner at Cooley, where he spent nearly a decade, and before that he was a partner at Goodwin Procter.
Davis, who also worked alongside Campbell at Cooley, focuses on patent, trade secret and unfair competition disputes involving technologies and medical devices in US district courts, the International Trade Commission, and the Patent Trial and Appeal Board at the US Patent and Trademark Office.
He has litigated cases in a range of fields, including semiconductors, artificial intelligence, cyber and network security, telecommunications networks and medical devices.
His previous firms include Hogan Lovells and Wilson Sonsini Goodrich & Rosati. Before beginning his legal career, he worked as an engineer for semiconductor manufacturer Veeco Instruments, Inc.
Chan litigates and licenses complex intellectual property cases on behalf of universities, research institutions and technology companies.
His work is primarily focused on semiconductors and technology-intensive matters involving electronics, as well as biomaterials and medical devices. He represents plaintiffs and defendants in US district courts and before the US Court of Appeals for the Federal Circuit. Internationally, he has worked on matters in China, Taiwan, Japan, Korea and Europe.
Chan spent a year and a half at King & Spalding, which he joined from McKool Smith, where he was a principal.
Campbell commented: “Having watched our IP team flourish these last few years, particularly in our representation of patent stakeholders including universities, we are truly excited to join the world-class IP group at Cahill.”
Gerald J Flattmann Jr, co-chair of Cahill’s life sciences patent litigation and IP litigation practice groups, commented that he previously practised alongside the new recruits at King & Spalding. “Having worked seamlessly alongside them for many years, I am thrilled they are joining our growing team.”
The New York-headquartered firm has four offices, three in the US and one in London. It opened its Delaware office last year.
Email your news and story ideas to: [email protected]
